Additional Information for Gefitinib Tablets
Gefitinib Tablets are a type of medication that falls under the supply class Drugs And Biologicals in the supply group Medical, Dental, And Veterinary Equipment And Supplies. Gefitinib is an oral medication that belongs to a class of drugs called tyrosine kinase inhibitors. It is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has specific mutations in the epidermal growth factor receptor (EGFR) gene.
Gefitinib works by blocking the activity of the EGFR protein, which is involved in the growth and spread of cancer cells. By inhibiting this protein, Gefitinib helps to slow down or stop the growth of cancer cells, thereby reducing the size of tumors and preventing their spread to other parts of the body.
Gefitinib Tablets are typically prescribed by healthcare professionals and should be taken exactly as directed. It is important to follow the prescribed dosage and schedule, as well as any additional instructions provided by the healthcare provider.
As with any medication, Gefitinib Tablets may have potential side effects. Common side effects may include diarrhea, skin rash, acne, dry skin, nausea, and loss of appetite. It is important to report any side effects to the healthcare provider for proper management.
Please note that this information is for general knowledge purposes only and should not replace the advice of a healthcare professional. It is always recommended to consult with a healthcare provider or pharmacist for specific information about Gefitinib Tablets or any other medication.
Related Item Names for INC 68818 Gefitinib Tablets
NATO Stock Numbers with Item Name 68818 Gefitinib Tablets Page 1 of 1
- 3400939595078
- RNCC: 3 | RNVC: 2 | DAC: 4